Changes in thymosin-alpha(1)content in patients with nonspecific gynecologic diseases depending on inflammation type and efficacy of antiinflammatory and immunomodulating therapy.
Plasma content of thymosin-alpha(1)and its circadian variations in patients with inflammatory gynecologic diseases differ from those in healthy donors and depend on the type of inflammation and efficacy of treatment. It is concluded that not only the absolute content of thymic hormones, but also their biorhythmic variations are important for immune regulation.
Shurlygina
A
A
Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk. A.V.Shurlygina@iph.ma.nsc.ru
Litvinenko
G
G
Dergacheva
T
T
Trufakin
V
V
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007249:Inflammation; D012488:Salpingitis / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D013947:Thymosin / Q000097:blood*
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D013947:Thymosin